- $595.60m
- $543.08m
- $880.69m
- 83
- 95
- 75
- 98
Annual cashflow statement for PHI, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | PROSPECTUS/A | PROSPECTUS/A |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | 69.8 | 57.6 | 100 |
| Depreciation | |||
| Deferred Taxes | |||
| Non-Cash Items | 7.82 | 6.01 | -2.4 |
| Unusual Items | |||
| Equity in Net Earnings/Losses | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -19.5 | -55.6 | -31.8 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Payable / Accrued Expenses | |||
| Change in Other Liabilities | |||
| Cash from Operating Activities | 109 | 54.2 | 143 |
| Capital Expenditures | -28.2 | -36.9 | -67.8 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | 3.48 | 0.563 | 8.09 |
| Sale of Fixed Assets | |||
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -24.7 | -36.3 | -59.7 |
| Financing Cash Flow Items | 0 | -15.4 | -21 |
| Other Financing Cash Flow | |||
| Total Cash Dividends Paid | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | -86.4 | -20.1 | -64.3 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -2.36 | -1.9 | 19.6 |